These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25210015)

  • 1. Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
    Aparicio J; Maroto P; García Del Muro X; Sánchez-Muñoz A; Gumà J; Margelí M; Sáenz A; Sagastibelza N; Castellano D; Arranz JA; Hervás D; Bastús R; Fernández-Aramburo A; Sastre J; Terrasa J; López-Brea M; Dorca J; Almenar D; Carles J; Hernández A; Germà JR
    Ann Oncol; 2014 Nov; 25(11):2173-2178. PubMed ID: 25210015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
    Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
    Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
    Aparicio J; Sánchez-Muñoz A; Gumà J; Domenech M; Meana JA; García-Sánchez J; Bastús R; Gironés R; González-Billalabeitia E; Sagastibelza N; Ochenduszko S; Sánchez A; Terrasa J; Germà-Lluch JR; García Del Muro X;
    Oncology; 2018; 95(1):8-12. PubMed ID: 29587278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
    Tandstad T; Ståhl O; Dahl O; Haugnes HS; Håkansson U; Karlsdottir Å; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Stierner U; Cavallin-Ståhl E; Wahlqvist R; Wall N; Cohn-Cedermark G;
    Ann Oncol; 2016 Jul; 27(7):1299-304. PubMed ID: 27052649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.
    Aparicio J; García del Muro X; Maroto P; Paz-Ares L; Alba E; Sáenz A; Terrasa J; Barnadas A; Almenar D; Arranz JA; Sánchez M; Fernández A; Sastre J; Carles J; Dorca J; Gumà J; Yuste AL; Germà JR;
    Ann Oncol; 2003 Jun; 14(6):867-72. PubMed ID: 12796024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
    Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
    J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
    Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
    Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
    Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
    J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.
    Tyrrell HEJ; Church DN; Joseph J; Traill ZC; Sullivan ME; Tuthill MH; Verrill CL; Pintus EP; Dallas NL; Rogers PB; Redgwell J; Protheroe AS
    Clin Genitourin Cancer; 2018 Jun; 16(3):240-244. PubMed ID: 29336917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular seminoma: Are clinical features and treatment outcomes any different in India?
    Anjanappa M; Kumar A; Mathews S; Joseph J; Jagathnathkrishna KM; James FV
    Indian J Cancer; 2017; 54(1):385-387. PubMed ID: 29199728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
    Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
    Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.